{"product_id":"asn-kidney-week-diabetes-management-for-the-nephrology-care-team-2025-videos","title":"ASN Kidney Week Diabetes Management for the Nephrology Care Team 2025 (Videos)","description":"\u003cdiv class=\"row\"\u003e\r\n\u003cdiv class=\"columns small-12 medium-12 large-12 sidebar-full\"\u003e\r\n\u003ch3 data-path-to-node=\"2\"\u003eASN Kidney Week Diabetes Management for the Nephrology Care Team 2025 (Videos)\u003c\/h3\u003e\r\n\u003cp data-path-to-node=\"2\"\u003eThe \u003cb data-path-to-node=\"2\" data-index-in-node=\"4\"\u003eDiabetes Management for the Nephrology Care Team\u003c\/b\u003e was a full-day \u003cb data-path-to-node=\"2\" data-index-in-node=\"68\"\u003eEarly Program\u003c\/b\u003e held immediately prior to the main ASN Kidney Week 2025 Annual Meeting. This course was designed to address the “technological revolution” in diabetes care—specifically the rapid adoption of Continuous Glucose Monitoring (CGM) and automated insulin delivery systems—and how these tools must be adapted for patients with Chronic Kidney Disease (CKD) and kidney failure.\u003c\/p\u003e\r\n\u003cp data-path-to-node=\"3\"\u003eHeld in \u003cb data-path-to-node=\"3\" data-index-in-node=\"8\"\u003eHouston\u003c\/b\u003e, the program emphasized a “team-based” approach, acknowledging that optimal diabetes management in nephrology requires coordination between nephrologists, pharmacists, and diabetes educators to manage complex new drug classes like GLP-1 receptor agonists and non-steroidal mineralocorticoid receptor antagonists (nsMRAs).\u003c\/p\u003e\r\n\r\n\u003ch3 data-path-to-node=\"4\"\u003e\u003cb data-path-to-node=\"4\" data-index-in-node=\"0\"\u003eWhat You Will Learn\u003c\/b\u003e\u003c\/h3\u003e\r\n\u003cp data-path-to-node=\"5\"\u003eThe curriculum focused on the practical implementation of new standards of care. Key learning outcomes included:\u003c\/p\u003e\r\n\r\n\u003cul data-path-to-node=\"6\"\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"6,0,0\"\u003e\u003cb data-path-to-node=\"6,0,0\" data-index-in-node=\"0\"\u003eCGM Mastery:\u003c\/b\u003e How to interpret Ambulatory Glucose Profiles (AGP) and “Time in Range” specifically for patients on dialysis, where traditional A1c metrics are often unreliable.\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"6,1,0\"\u003e\u003cb data-path-to-node=\"6,1,0\" data-index-in-node=\"0\"\u003eNew Therapeutics:\u003c\/b\u003e “How and for Whom” to prescribe new glucose-lowering therapies (SGLT2 inhibitors, GLP-1 RAs, GIP\/GLP-1 co-agonists) safely in advanced CKD and transplant recipients.\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"6,2,0\"\u003e\u003cb data-path-to-node=\"6,2,0\" data-index-in-node=\"0\"\u003eInsulin Automation:\u003c\/b\u003e Understanding the mechanics of “Closed-Loop” insulin pumps (Automated Insulin Delivery) and how to troubleshoot them in a hospital or dialysis setting.\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"6,3,0\"\u003e\u003cb data-path-to-node=\"6,3,0\" data-index-in-node=\"0\"\u003eBiomarker Nuances:\u003c\/b\u003e Beyond A1c—using glycated albumin and fructosamine to assess glycemic control in patients with anemia or high erythrocyte turnover.\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e","brand":"Amboss","offers":[{"title":"Default Title","offer_id":42954688823394,"sku":"MED-AMB08211","price":100.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/American-Society-of-Nephrology-Kidney-Week-Diabetes-Management-for-the-Nephrology-Care-Team-2025.webp?v=1779382485","url":"https:\/\/meducourse.com\/products\/asn-kidney-week-diabetes-management-for-the-nephrology-care-team-2025-videos","provider":"Meducourse","version":"1.0","type":"link"}